Compare TSSI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSSI | STXS |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.1M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | TSSI | STXS |
|---|---|---|
| Price | $7.03 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.1M | 409.8K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.63 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $234,837,000.00 | $30,075,000.00 |
| Revenue This Year | $54.04 | $24.21 |
| Revenue Next Year | N/A | $29.83 |
| P/E Ratio | $37.51 | ★ N/A |
| Revenue Growth | ★ 91.66 | 19.62 |
| 52 Week Low | $5.63 | $1.54 |
| 52 Week High | $31.94 | $3.59 |
| Indicator | TSSI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 32.82 | 41.72 |
| Support Level | $6.89 | $2.25 |
| Resistance Level | $7.97 | $2.48 |
| Average True Range (ATR) | 0.41 | 0.09 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 9.95 | 15.25 |
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.